World Library  
Flag as Inappropriate
Email this Article

Digoxin toxicity

Article Id: WHEBN0020807165
Reproduction Date:

Title: Digoxin toxicity  
Author: World Heritage Encyclopedia
Language: English
Subject: List of diseases (D), Taman Shud Case
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Digoxin toxicity

Digoxin toxicity
Classification and external resources
10 9 MedlinePlus 000165

Digoxin toxicity is a poisoning that occurs when excess doses of digoxin (from foxglove plants of the genus Digitalis) are consumed acutely or over an extended period. The classic features of digoxin toxicity are nonspecific: fatigue, blurred vision, change in color vision (e.g. "yellow vision"), anorexia, nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, confusion, delirium. It is also associated with characteristic cardiac arrhythmias.

Classification

Digoxin toxicity is often divided into acute or chronic. The therapeutic level for digoxin is 0.5-2 ng/mL. Low serum potassium increases the risk of digoxin toxicity and cardiac dysrhythmias. The classic arrhythmia is a paroxysmal atrial tachycardia with block. Digoxin toxicity occurs because it is very easy to overdose. Overdose commonly occurs because its therapeutic effect works only within a very narrow window.

Signs and symptoms

The symptoms of poisoning can include drowsiness, nausea/vomiting, loss of appetite (anorexia), diarrhea, disturbed color vision (yellow or green halos around objects), confusion, dizziness, agitation, and/or depression. Cardiac effects can include changes in heart rate and a variety of cardiac dysrhythmias. Hypokalemia is a characteristic sign of digoxin poisoning.[1]

Investigations

ECG

Characteristic EKG changes include bradycardia (the most frequent vital sign abnormality in toxicity), a prolonged PR interval. An accelerated junctional rhythm or bidirectional ventricular tachycardia suggests digoxin toxicity until proven otherwise.

Serum digoxin concentration

A serum digoxin concentration of 0.5-0.9 ng/mL was associated with reduced mortality and hospitalisations in the DIG (Digoxin Investigation Group) trial.[2] It is therefore recommended that digoxin concentration be maintained in approximately this range if it is used in heart failure.

Treatment

The primary treatment of digoxin toxicity is digoxin immune Fab, made up of anti-digoxin immunoglobulin fragments. The dose depends on the serum digoxin concentration and the weight of the patient.[3]

Other treatment that may be tried to treat life-threatening arrhythmias, until digoxin Immune Fab is acquired are magnesium, phenytoin, and lidocaine.[4] Atropine, catecholamines (isoprenaline or salbutamol), and/or temporary cardiac pacing may also used in cases of bradyarrhythmias.

References

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.